Understanding the Role of the 5-HT2B Receptor in Fibrosis with Special Focus on Systemic Sclerosis-ILD

Time: 5:00 pm
day: Day One


  • Exploring the mechanism of action
  • Using a variety of preclinical models to evaluate the therapeutic’s effectiveness
  • Harnessing RNA sequencing to show target engagement in relevant cells
  • Moving from Phase 1 into systemic sclerosis patients with focus on biomarkers